Goldman Sachs’s Kodiak Sciences KOD Stock Holding History

Goldman Sachs’s Portfolio KOD Stock Details KOD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-50,000	Closed	-$1.91M	–	6811
2026 Q1	$1.91M	Buy	+50,000	New	+$1.29M	﹤0.01%	4584

Other funds holding KOD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs's KOD Position: Q2 2026 in Review

Goldman Sachs increased its Kodiak Sciences (KOD) stake by 37% in Q2 2026, buying an estimated $24.4M and bringing the position to 2,316,014 shares worth $90.2M. The position accounts for 0.01% of the portfolio, ranked #1298.

Goldman Sachs first reported a position in KOD in Q4 2018 and has held it in 31 quarters since. 200 funds tracked by Wall St. Rank hold KOD as of Q2 2026.

Goldman Sachs held 2,316,014 shares of Kodiak Sciences worth $90.2M as of Q2 2026.
Goldman Sachs bought 627,011 Kodiak Sciences shares in Q2 2026, an estimated $24.4M.
Kodiak Sciences made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1298 holding.
Goldman Sachs first reported a position in Kodiak Sciences in Q4 2018 and has held it in 31 quarters since.
200 funds tracked by Wall St. Rank held Kodiak Sciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.